Results 291 to 295 of about 235,111 (295)
Some of the next articles are maybe not open access.
COVID-19 and Its Implications for Thrombosis and Anticoagulation
Seminars in Respiratory and Critical Care Medicine, 2021Venous thromboembolism, occlusion of dialysis catheters, circuit thrombosis in extracorporeal membrane oxygenation (ECMO) devices, acute limb ischemia, and isolated strokes, all in the face of prophylactic and even therapeutic anticoagulation, are ...
S. Berkman, V. Tapson
semanticscholar +1 more source
American Journal of Gastroenterology, 2021
INTRODUCTION: Current guidelines recommend anticoagulation as the mainstay of portal vein thrombosis (PVT) treatment in cirrhosis. However, because of the heterogeneity of PVT, anticoagulation alone does not always achieve satisfactory results.
Yong Lv +16 more
semanticscholar +1 more source
INTRODUCTION: Current guidelines recommend anticoagulation as the mainstay of portal vein thrombosis (PVT) treatment in cirrhosis. However, because of the heterogeneity of PVT, anticoagulation alone does not always achieve satisfactory results.
Yong Lv +16 more
semanticscholar +1 more source
Pediatric Critical Care Medicine, 2020
Objectives: Heparin is the universal anticoagulant for patients receiving extracorporeal membrane oxygenation support. However, heparin has many disadvantages, especially in young children, who develop heparin resistance.
M. Hamzah +3 more
semanticscholar +1 more source
Objectives: Heparin is the universal anticoagulant for patients receiving extracorporeal membrane oxygenation support. However, heparin has many disadvantages, especially in young children, who develop heparin resistance.
M. Hamzah +3 more
semanticscholar +1 more source
Journal of the American Medical Association (JAMA), 2001
A. Go +6 more
semanticscholar +1 more source
A. Go +6 more
semanticscholar +1 more source
Portal vein thrombosis: yes or no on anticoagulation therapy
Current Opinion in Organ Transplantation, 2018Fanny Turon +2 more
semanticscholar +1 more source

